TL;DR

An increasing number of cancer patients are using ivermectin, a drug not approved for cancer treatment. The trend appears linked to public endorsements by Mel Gibson and Joe Rogan, prompting health concerns.

Medical authorities confirm that more cancer patients are now using ivermectin, a drug primarily approved for parasitic infections, amid growing celebrity influence and misinformation.

Recent reports indicate a significant rise in the number of cancer patients taking ivermectin outside of approved medical protocols. This trend has been linked, in part, to public endorsements by actor Mel Gibson and podcast host Joe Rogan, who have promoted the drug as a potential treatment for various illnesses, including cancer.

Health experts warn that ivermectin is not approved for cancer treatment and that its use in this context can be dangerous. The FDA has issued warnings against using ivermectin for unapproved purposes, citing potential side effects and lack of scientific evidence supporting its efficacy against cancer.

While some patients report anecdotal benefits, medical professionals emphasize that there is no rigorous clinical evidence to support ivermectin as an effective cancer therapy. The increase in its use raises concerns about unproven treatments delaying standard, evidence-based care.

Why It Matters

This trend underscores the impact of celebrity influence and misinformation on public health decisions. The use of unapproved treatments like ivermectin can lead to adverse health outcomes and complicate cancer management. It also highlights the ongoing challenge for authorities to counteract false health claims circulating online and through social media.

Amazon

ivermectin supplement for parasitic infections

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Background

Since the COVID-19 pandemic, ivermectin gained popularity among certain groups as a supposed cure for various ailments, despite lacking approval for such uses. The drug’s promotion by public figures has amplified its visibility, leading some patients to self-medicate without medical guidance. The recent increase in cancer patients using ivermectin appears to be a continuation of this trend, now extending beyond COVID-19 misinformation.

“Using ivermectin for cancer is unsupported by scientific evidence and can be potentially harmful. Patients should consult their healthcare providers before trying unapproved treatments.”

— Dr. Lisa Montgomery, oncologist

“Ivermectin has shown some promising results in anecdotal reports, but it’s not a substitute for proven cancer treatments.”

— Joe Rogan, podcast host

Amazon

medical-grade ivermectin

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

What Remains Unclear

It is still unclear how widespread the use of ivermectin among cancer patients has become nationally or globally. The exact influence of celebrity endorsements versus other factors remains under investigation. Additionally, data on health outcomes for patients using ivermectin in this context are limited and not yet conclusive.

MARYRUTH'S Organic Lymphatic Support Liquid Drops, Herbal Blend, Non-GMO

MARYRUTH'S Organic Lymphatic Support Liquid Drops, Herbal Blend, Non-GMO

  • Supports Lymphatic System: Promotes immune health and fluid balance
  • Herbal Blend Benefits: Contains 8 traditional herbs for support
  • Organic & Natural Ingredients: USDA Organic, non-GMO, alcohol-free

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

What’s Next

Health authorities are expected to monitor the trend closely, issue further warnings, and possibly investigate the extent of ivermectin use among cancer patients. Medical professionals will continue to advocate for evidence-based treatments, and researchers may explore the impact of misinformation on health behaviors.

Naturally Supporting Cancer Treatment: Evidence-based ways to help prevent cancer formation and recurrence, and assist treatment

Naturally Supporting Cancer Treatment: Evidence-based ways to help prevent cancer formation and recurrence, and assist treatment

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Key Questions

Why are more cancer patients taking ivermectin?

Some patients are influenced by celebrity endorsements and misinformation suggesting ivermectin might be effective against cancer, despite a lack of scientific evidence.

Is ivermectin approved for cancer treatment?

No, ivermectin is not approved for treating cancer. It is only approved for parasitic infections and should only be used under medical supervision for approved indications.

What are the risks of using ivermectin for unapproved purposes?

Unapproved use of ivermectin can cause adverse side effects, including neurological issues, and may delay access to proven, effective cancer therapies.

How are health authorities responding?

Authorities are warning the public against using ivermectin for unapproved purposes and are investigating the rise in its use among cancer patients.

What role do celebrities play in this trend?

Public endorsements by figures like Mel Gibson and Joe Rogan appear to influence some patients’ decisions to try ivermectin for cancer, despite lack of scientific support.

You May Also Like

How to Come Into This Challenging Arm Balance, One Step at a Time

Learn how to approach Firefly Pose (Tittibhasana) gradually with practical tips, key preparatory poses, and expert advice to build strength and flexibility.

PGSimCity – How PostgreSQL Works

An in-depth look at how PostgreSQL database technology is used in PGSimCity to manage complex city simulation data.

Why Brightspring Health Services Is Leading In Global Healthcare Coverage

Brightspring Health Services is rapidly expanding its global healthcare coverage, positioning itself as a leader in the industry.

Don’t freak out about hantavirus

Eighteen Americans exposed to hantavirus after cruise; authorities confirm containment and monitoring, emphasizing low risk of widespread transmission.